Xeomin 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26F5Z49
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,009
Award facts
- Contract value 100% obligated
- $15,008.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 23, 2026, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 100-unit vials of Xeomin (an injectable botulinum toxin product) with a ceiling value of $15,008.50. The contract is a firm fixed-price delivery order with no set-aside designation, executed competitively. Performance will be completed by February 13, 2026, at the awardee's facility in Conshohocken, Pennsylvania. This order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with the DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the child entity of parent company Cencora, Inc. (doing business as AmerisourceBergen). The company is registered in the System for Award Management and has demonstrated capability to meet federal procurement requirements through multiple competitive awards across diverse pharmaceutical portfolios. The Defense Logistics Agency Troop Support Medical is planning to establish the Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards for separate regions, positioning AmerisourceBergen to continue serving critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F5Z49?
SPE2DR26F5Z49 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F5Z49 worth?
The government has obligated $15,009 on SPE2DR26F5Z49.
Is contract SPE2DR26F5Z49 an order under another contract?
Yes. SPE2DR26F5Z49 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5Z49 competed?
The extent of competition for SPE2DR26F5Z49 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award